0.821
price down icon2.94%   -0.0249
after-market Handel nachbörslich: .83 0.009 +1.10%
loading

Applied Dna Sciences Inc Aktie (APDN) Neueste Nachrichten

pulisher
May 09, 2025

Applied Dna Sciences Inc (APDN)’s Day in Review: Closing at 0.85, Down by -2.41 - DWinneX

May 09, 2025
pulisher
May 06, 2025

Applied DNA Sciences Inc expected to post a loss of $3.00 a shareEarnings Preview - TradingView

May 06, 2025
pulisher
May 05, 2025

Geode Capital Management LLC Grows Holdings in Applied DNA Sciences, Inc. (NASDAQ:APDN) - Defense World

May 05, 2025
pulisher
May 02, 2025

Applied Dna Sciences Inc (APDN) is an excellent investment, but the stock is overvalued/undervalued right now - uspostnews.com

May 02, 2025
pulisher
May 02, 2025

Applied DNA Sciences (APDN) to Release Quarterly Earnings on Friday - Defense World

May 02, 2025
pulisher
Apr 30, 2025

Investing in Applied Dna Sciences Inc (APDN) Is Getting More Attractive - knoxdaily.com

Apr 30, 2025
pulisher
Apr 30, 2025

Ratios Revealed: Decoding Applied Dna Sciences Inc (APDN)’s Financial Health - DWinneX

Apr 30, 2025
pulisher
Apr 30, 2025

Applied DNA Sciences, Inc. (NASDAQ:APDN) Short Interest Update - Defense World

Apr 30, 2025
pulisher
Apr 29, 2025

Financial Analysis: Applied Dna Sciences Inc (APDN)’s Ratios Unveil Key Insights - DWinneX

Apr 29, 2025
pulisher
Apr 29, 2025

Press Release Distribution & PR Platform - ACCESS Newswire

Apr 29, 2025
pulisher
Apr 26, 2025

Analysts Say Applied Dna Sciences Inc (NASDAQ:APDN) Can Really Get To 1.5 In 12 Months - Marketing Sentinel

Apr 26, 2025
pulisher
Apr 23, 2025

Applied Dna Sciences Inc [APDN] Investment Appeal on the Rise - knoxdaily.com

Apr 23, 2025
pulisher
Apr 23, 2025

Market Highlights: Applied Dna Sciences Inc (APDN) Ends on a High Note at 0.90 - DWinneX

Apr 23, 2025
pulisher
Apr 22, 2025

Applied Dna Sciences Inc (APDN) Stock: A 52-Week Tale of Drops and Gains - investchronicle.com

Apr 22, 2025
pulisher
Apr 22, 2025

APDN’s earnings estimates: Are they on track to meet expectations? - uspostnews.com

Apr 22, 2025
pulisher
Apr 22, 2025

Applied DNA Sciences (APDN) Enhances U.S. Supply Chain for Genetic Medicine Platforms | APDN Stock News - GuruFocus

Apr 22, 2025
pulisher
Apr 21, 2025

Applied DNA secures U.S. supply chain for key materials By Investing.com - Investing.com Canada

Apr 21, 2025
pulisher
Apr 21, 2025

Applied DNA Sciences (APDN) Enhances U.S. Supply Chain for Genet - GuruFocus

Apr 21, 2025
pulisher
Apr 21, 2025

Applied DNA secures U.S. supply chain for key materials - Investing.com

Apr 21, 2025
pulisher
Apr 21, 2025

Applied DNA's LineaRx Subsidiary Stands Ready to Support the Reshoring of Drug Development and Manufacturing with U.S.-Produced Synthetic DNA | APDN Stock News - GuruFocus

Apr 21, 2025
pulisher
Apr 21, 2025

Applied DNA's LineaRx Subsidiary Stands Ready to Support the Reshoring of Drug Development and Manufacturing with U.S.-Produced Synthetic DNA - The Joplin Globe

Apr 21, 2025
pulisher
Apr 21, 2025

US Biotech Leader LineaRx Transforms DNA Manufacturing with Major Domestic Supply Chain Shift - Stock Titan

Apr 21, 2025
pulisher
Apr 15, 2025

APDN stock plunges to 52-week low at $0.89 amid market challenges By Investing.com - Investing.com South Africa

Apr 15, 2025
pulisher
Apr 15, 2025

APDN stock plunges to 52-week low at $0.89 amid market challenges - Investing.com Canada

Apr 15, 2025
pulisher
Apr 14, 2025

Applied DNA regains compliance with Nasdaq minimum bid price rule - MSN

Apr 14, 2025
pulisher
Apr 14, 2025

12 Health Care Stocks Moving In Monday's Intraday Session - Benzinga

Apr 14, 2025
pulisher
Apr 08, 2025

Applied DNA regains Nasdaq compliance with bid price By Investing.com - Investing.com South Africa

Apr 08, 2025
pulisher
Apr 08, 2025

Applied DNA Sciences Regains Nasdaq Compliance on Minimum Bid Price Rule - MarketScreener

Apr 08, 2025
pulisher
Apr 08, 2025

Applied DNA Sciences regains Nasdaq compliance with stock price By Investing.com - Investing.com South Africa

Apr 08, 2025
pulisher
Apr 08, 2025

Applied DNA regains Nasdaq compliance with bid price - Investing.com

Apr 08, 2025
pulisher
Apr 08, 2025

Applied DNA Sciences regains Nasdaq compliance with stock price - Investing.com

Apr 08, 2025
pulisher
Apr 08, 2025

Applied DNA Regains Compliance with Nasdaq Minimum Bid Price Requirement - Weatherford Democrat

Apr 08, 2025
pulisher
Apr 08, 2025

Applied DNA Overcomes Delisting Threat: Successfully Maintains Nasdaq Standards - Stock Titan

Apr 08, 2025
pulisher
Apr 07, 2025

APDN stock plunges to 52-week low at $1.14 amid steep decline - Investing.com Australia

Apr 07, 2025
pulisher
Apr 07, 2025

APDN stock plunges to 52-week low at $1.14 amid steep decline By Investing.com - Investing.com South Africa

Apr 07, 2025
pulisher
Apr 01, 2025

Applied DNA sets May 22 for virtual shareholder meeting By Investing.com - Investing.com India

Apr 01, 2025
pulisher
Apr 01, 2025

Applied DNA sets May 22 for virtual shareholder meeting - Investing.com

Apr 01, 2025
pulisher
Apr 01, 2025

Growth or Bubble? APDN’s Unexpected Surge - timothysykes.com

Apr 01, 2025
pulisher
Apr 01, 2025

Why Applied DNA Sciences (APDN) Stock Is Rising - Benzinga

Apr 01, 2025
pulisher
Apr 01, 2025

Applied DNA refines pharmacogenomics strategy By Investing.com - Investing.com Australia

Apr 01, 2025
pulisher
Apr 01, 2025

Applied DNA refines pharmacogenomics strategy - Investing.com

Apr 01, 2025
pulisher
Apr 01, 2025

Applied DNA Positions TR8 PGx Testing Service as Pre-Emptive Testing for Safety of Fluoropyrimidine-Based Cancer Therapeutics Following Publication of Food and Drug Administration Safety Announcement - ACCESS Newswire

Apr 01, 2025
pulisher
Apr 01, 2025

Critical FDA Safety Alert Powers Applied DNA's New Cancer Drug Testing Solution - Stock Titan

Apr 01, 2025
pulisher
Mar 31, 2025

APDN stock plunges to 52-week low at $1.63 amid steep decline - Investing.com Canada

Mar 31, 2025
diagnostics_research DGX
$176.96
price up icon 0.60%
diagnostics_research LH
$245.73
price down icon 1.22%
diagnostics_research WAT
$344.06
price down icon 1.94%
$151.95
price down icon 6.53%
diagnostics_research MTD
$1,080.98
price down icon 1.87%
diagnostics_research IQV
$148.99
price down icon 2.81%
Kapitalisierung:     |  Volumen (24h):